Therefore, we aimed to evaluate whether circulating antioxidant (Nrf2 and glutathione) and oxidative damage markers (MDA and protein carbonyl) concentration changes according to disease severity in DMD patients. The gene discussed is NFE2L2; the disease is Duchenne muscular dystrophy.